PRKAA2 and medulloblastoma: Thus, the AMPKα2 KO mice have a significantly lower chance of developing medulloblastoma compared to the AMPKα2 WT mice [59% (10/17) for AMPKα2 KO versus 100% (12/12) for AMPKα2 WT; p = 0.0027].